Researchers used the Premier Healthcare Database to compare Clostridioides difficile prevalence and inpatient outcomes in the pre-COVID-19 period, April 2019 to March 2020, and COVID-19 period, April 2020 to March 2021, for 25,991 patients.
Cases of Clostridioides difficile infections declined from 12.2 per 10,000 encounters pre-COVID-19 to 8.9 per 10,000 encounters during the pandemic. Despite the drop, patients did experience an uptick in inpatient mortality during the pandemic to 7.4 percent. Higher median encounter costs were also observed, with an average increase of approximately $2,000.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
